Concepedia

Laura Godfrey

LG

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

1991

Affiliations

University of Oxford(Current)

MRC Weatherall Institute of Molecular Medicine

Oxford BioMedica (United Kingdom)

MRC Human Immunology Unit

University of California, San Francisco

Laura Godfrey is an author at University of Oxford specializing in molecular biology, life sciences, and molecular oncology.

ORCID

Publications per year

1991–2023

13

Publications

13

DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation

Laura Godfrey, Nicholas T. Crump, Ross Thorne et al. · Nature Communications · 2019 · 168 citations · Full text

, , +17

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Juliana M. Benito, Laura Godfrey, Kensuke Kojima et al. · Cell Reports · 2015 · 155 citations · Full text

, , +16

BET inhibition disrupts transcription but retains enhancer-promoter contact

Nicholas T. Crump, Erica Ballabio, Laura Godfrey et al. · Nature Communications · 2021 · 129 citations · Full text

, , +17

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia

Jon Kerry, Laura Godfrey, Emmanouela Repapi et al. · Cell Reports · 2017 · 94 citations · Full text

, , +14

Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs

Sorcha O’Byrne, Natalina Elliott, Siobhan Rice et al. · Blood · 2019 · 94 citations · Full text

, , +12

1–5 of 13